Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse

Masahiro Shuda1, Anna Guastafierro1, Xuehui Geng2

  • 1Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

Plos One
|November 7, 2015
PubMed

Insights

Merkel cell polyomavirus small T antigen drives cancer. Conditional expression in mice revealed its oncogenic potential, particularly in p53-deficient settings, leading to tumor formation and cell transformation.

Area of Science:

  • Oncology
  • Virology
  • Genetics

Background:

  • Merkel cell polyomavirus (MCV) is a primary cause of Merkel cell carcinoma (MCC).
  • The MCV small T (sT) antigen possesses transforming capabilities in vitro.
  • A conditional mouse model is needed to study MCV sT-induced carcinogenesis in vivo.

Purpose of the Study:

  • To develop and characterize a conditional transgenic mouse model for MCV sT-induced carcinogenesis.
  • To investigate the oncogenic role of MCV sT in different cellular and genetic contexts.
  • To explore the impact of MCV sT on Merkel cell development and tumorigenesis.

Main Methods:

  • Generation of ROSAsT transgenic mice with conditional MCV sT expression.
  • Tamoxifen-inducible Cre-mediated recombination for spatio-temporal control of sT expression.
  • Analysis of tumor development in wild-type and p53-deficient mice.
  • Assessment of Merkel cell proliferation during embryogenesis.

Main Results:

  • Ubiquitous MCV sT expression in adult mice led to rapid lethality or non-specific hyperplasia.
  • Conditional sT expression in p53-null mice induced aggressive, multi-focal tumors in spleen and liver.
  • MCV sT expression in embryonic progenitor Merkel cells increased their numbers transiently.
  • Mouse embryonic fibroblasts expressing MCV sT exhibited anchorage-independent growth.

Conclusions:

  • MCV sT is a potent viral oncoprotein capable of inducing full cancer cell transformation.
  • The p53 tumor suppressor pathway is critical in suppressing MCV sT-driven tumorigenesis.
  • MCV sT can influence progenitor cell proliferation during development, but tumorigenesis requires specific conditions.